Nicotine effects on adults with attention-deficit/hyperactivity disorder

Psychopharmacology

Volumn 123, Issue 1, 1996, Pages 55-63

  Levin, E D ^a   Conners, C K ^a   Sparrow, E ^a   Hinton, S C ^a   Erhardt, D ^a   Meck, W H ^a   Rose, J E ^a   March, J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Attention; Attention Deficit Hyperactivity Disorder; Nicotine; Nicotine skin patches; Treatment

Indexed keywords

NICOTINE; PLACEBO;

ACCURACY; ADULT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERACTIVITY; MALE; MOOD; PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; REACTION TIME; TIME PERCEPTION; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADULT; ANALYSIS OF VARIANCE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; MIDDLE AGED; NICOTINE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REACTION TIME; SMOKING;

EID: 0030051876     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246281     Document Type: Article

References (58)

1. Ahtee L, Kaakkola S (1978) Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain: Interaction with morphine and haloperidol. Br J Pharmacol 62:213-218
2. Barkley R (1990) Attention deficit hyperactivity disorder: a handbook for diagnosis and treatment Guildford, New York
3. Barkley RA (1995) Impaired delayed responding: a unified theory of attention deficit hyperactivity disorder. In: Routh DK (ed) Disruptive behavior disorders in childhood: essays Honoring Herbert C. Quay. Plenum, New york, pp 1-73
4. Benowitz NL (1993) Nicotine replacement therapy: what has been accomplished-can we do better? Drugs 45:157-170
5. Church R, Miller KD, Meck WH, Gibbon J (1991) Symmetrical and asymmetrical sources of variance in temporal generalization. Anim Learn Behav 19:207-214
6. Clarke PBS, Hommer DW, Pert A, Skirboll LR (1985) Electrophysiological actions of nicotine on substantial nigra single units. Br J Pharmacol 85:827-835
7. Clarke PBS, Pert A (1985) autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358
8. Clarke PBS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390-395
9. Cloninger CR, Przybeck TR, Svrakic DM (1991) The Tridimensional Personality Questionnaire: US normative data. Psychol Rep 69:1047-1057
10. Conners CK (1994) The Continuous Performance Test (CPT): use as a diagnostic tool and measure of treatment outcome. Annal Convention of the American Psychological Association. Los Angeles, Calif.
11. Conners CK (1995) The Continuous Performance Test. Multi-Helath Systems, Toronto
12. Conners CK, March JS, Fiore C, Butcher T (1994) Information processing deficits in ADHD: effect of stimulus rate and methylphenidate. Annual Meeting of the American College of Neuropsychopharmacology
13. Derogatis LR (1983) SCL-90-R; administration scoring and procedures manual-II Clinical Psychometric Research., Towson, md.
14. DSM-IV Task Force (1994) Diagnostic and statistical manual for mental disorders: DSM-IV. American Psychiatric Association. Washington, D.C.
15. Fagerstrom KO, Schneider NG (1989) Measuring nicotine dependence; a review of the Fagerström tolerance questionnaire. J Behav Med 12:159-182
16. Fagerström KO, Pomerleau O, Giordani B, Stelson F (1994) Nicotine may relieve symptoms of Parkinson's disease. Psychopharmacology 116:117-119
17. Grenhoff J, Aston-Jones G, Svensson TH (1986) Nicotinic effects on the firing pattern of midbrain dopaminc neurons. Acta Physiol Scand 128:151-158
18. Haikala H, Ahtee L (1988) Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine. Naunyn Schmiedberg's Arch Pharmacol 338:169-173
19. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
20. Hatsukami D, Fletcher L, Morgan S, Keenan R, Amble P (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J Subst Abuse 1:407-416
21. Henningfield JE (1984) Behavioral pharmacology of cigarette smoking. Adv Behav Pharmacol 4:131-210
22. Hughes JR (1989) Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother 43:11-17
23. Ikard FF, Green DE, Horn O (1969) A scale to differentiate between types of smoking as related to the management of affect. Int J Addict 4:649-659
24. Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338
25. Jarvik ME (1991) Beneficial effects of nicotine. Br J Addict 86:571-575
26. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494
27. Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417-431
28. Levin ED, Rose JE (1995) Acute and chronic nicotinic interactions with dopamine systems and working memory performance. In: Lajtha A, Abood L (eds) Functional diversity of interacting receptors. New York Academy of Sciences, New York, pp 218-221
29. Levin ED, Rosecrans J (1994) The promise of nicotinic-based therapeutic treatments. Drug Dev Res 31:1-2
30. Levin ED, Karan L, Rosecrans J (1993) Nicotine: an addicitive drug with therapeutic potential. Med Chem Res 2:509-513
31. McConville BJ, Fogelson MH, Norman AB, Klykylo WM, Manderschied PZ, Parker KW, Sanberg PR (1991) Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. Am J Psychiatry 148:793-794
32. McNair DM, Lorr M, Droppleman LF (1981) EdITs manual for the profile of mood states. Educational and Industrial Testing Service, San Diego
33. Meck WH, Church RM (1987) Cholinergic modulation of the content of temporal memory. Behav Neurosci 101:207-214
34. Meru G, Yoon KP, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395-399
35. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95:171-175
36. NIMH (1985) CGI (Clinical Global Impression) scale. Psychopharmacol Bull 21:839-843
37. Palmer KJ, Buckley MM, Faulds D (1992) Transdermal nicotine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an aid to smoking cessation Drugs. 44:498-529
38. Peeke SC, Peeke HVS (1984) Attention, memory, and cigarette smoking. Psychopharmacology 84:205-216
39. Penney TB, Williams CL, Meck WH (1993) Developmental dyslexia and additional processing in a temporal bisection task. 21st Annual Meeting of the International Society for Developmental Psychobiology. Alexandria, Va.
40. Pickworth WB, Bunker EB, Henningfield JE (1994) Transdermal nicotine: reduction of smoking with minimal abuse liability. Psychopharmacology 115:9-14
41. Pomerleau CS, Downey KK, Stelson FW, Pomerleau OF (1995a) Smoking and adult ADHD: a connection? J Addict Dis (in press)
42. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1995b) Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse(in press)
43. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, Newcombe RG, Russell MAH, Feyerabend C, Thomas GAO, Sawe U (1994) Transdermal nicotine for active ulcerative colitis. N Engl J Med 330: 811-815
44. Sahakian BJ, Jones GMM (1991) The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K (eds) Effects of nicotine on biological systems. Birkhauser Verlag, Basel, pp 623-230
45. 3H] acctylcholine in rat brain. Life Sci 38:2111-2119
46. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-661
47. Warburton DM, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmacology 115:539-542
48. Warburton DM, Rusted JM, Fowler J (1992) A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108:443-447
49. Wearden JH, McShane B (1988) Interval production as an analogue of the peak procedure: Evidence for similarity of human and animal timing process. Q J Exp Psychol 40B:363-375
50. Wender P (1995) Attention-deficit hyperactivity disorder in adults. Oxford University Press, New York
51. Wender PH, Wood DR, Reimherr FW (1991) Pharmacological treatment of attention deficit disorder, residual type (ADD-RT) in adults. In: Greenhill LL, Osman BB (ed) Ritalin: theory and patient management. Mary Ann Liebert, New York, pp 25-33
52. Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther. 21:189-208
53. Wesnes K, Warburton DM (1984a) The effects of cigarettes of varying yield on rapid information processing performance. Psychopharmacology 82:338-342
54. Wesnes K, Warburton DM (1984b) Effects of scopolamine and nicotine on human rapid information information processing performance. Psychopharmacology 82:147-150
55. Wesnes K, Warburton DM, Matz B (1983) Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 9:41-44
56. Westman E, Levin E, Rose J (1995) Nicotine as a therapeutic drug. NC Med J 56:2-5
57. Williams JBW (1988) A structured interview guide for the Hamilton depression rating scale. Arch Gen Psychiatry 45:742-747
58. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (ed) Progress in brain research. Elsevier Science Publishers B.V., New York, pp 157-163